Herpes zoster with other nervous system involvement
ICD-10 B02.2 is a billable code used to indicate a diagnosis of herpes zoster with other nervous system involvement.
Herpes zoster, commonly known as shingles, is a viral infection caused by the reactivation of the varicella-zoster virus (VZV), which also causes chickenpox. This condition is characterized by a painful rash that typically appears on one side of the body or face. When herpes zoster is associated with other nervous system involvement, it can lead to complications such as postherpetic neuralgia, meningitis, or encephalitis. Patients may experience severe pain, sensory disturbances, and neurological deficits depending on the areas affected. The incidence of herpes zoster increases with age and is more common in individuals with weakened immune systems. Vaccination against VZV is recommended for older adults to reduce the risk of developing herpes zoster and its complications. The clinical management of herpes zoster may include antiviral medications, pain management, and supportive care. Accurate coding is essential for proper treatment reimbursement and tracking of healthcare outcomes.
Detailed neurological examination findings, imaging results, and treatment plans.
Patients presenting with severe pain and neurological deficits following herpes zoster.
Ensure comprehensive documentation of neurological assessments and any interventions performed.
History of varicella infection, vaccination status, and treatment response.
Patients with recurrent herpes zoster or those with atypical presentations.
Document any co-infections or complications that may arise.
Administering the shingles vaccine to prevent herpes zoster.
Document vaccine type, administration date, and patient consent.
Ensure proper coding for vaccine administration in relation to patient age and health status.
Common complications include postherpetic neuralgia, herpes zoster ophthalmicus, and neurological conditions such as meningitis and encephalitis.
